Related Experiment Video
Updated: Aug 23, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Antibody-Antimicrobial Conjugates for Combating Antibiotic Resistance
Luofeng Yu1, Zifang Shang1,2,3, Qizhe Jin1
1Frontiers Science Center for Flexible Electronics (FSCFE), Xi'an Institute of Flexible Electronics (IFE), Xi'an Institute of Biomedical Materials and Engineering (IBME), Northwestern Polytechnical University (NPU), 127 West Youyi Road, Xi'an, 710072, China.
Antibody-antimicrobial conjugates (AACs) offer a promising strategy against drug-resistant bacteria by precisely delivering antimicrobial agents. This review details AAC components, conjugation methods, and applications, addressing challenges and future opportunities in combating antimicrobial resistance.
Area of Science:
- Microbiology
- Immunology
- Pharmacology
Background:
- Antibiotic development is lagging behind the rise of drug-resistant bacteria, necessitating novel therapeutic strategies.
- Antibody-drug conjugates (ADCs) show promise for targeted delivery of cytotoxic agents.
- Antibody-antimicrobial conjugates (AACs) are emerging as a potent approach to combat bacterial infections and mitigate antimicrobial resistance.
Purpose of the Study:
- To review the essential components of Antibody-antimicrobial conjugates (AACs): antibodies, antimicrobial payloads, and linkers.
- To summarize conjugation strategies and recent applications of AACs in treating bacterial infections.
- To discuss the challenges and future opportunities for this therapeutic technology.
Main Methods:
- Literature review of scientific publications on Antibody-antimicrobial conjugates (AACs).
- Analysis of antibody selection, antimicrobial payload characteristics, and linker technologies.
- Summary of conjugation methods and recent case studies of AAC applications.
Main Results:
- AACs enable targeted delivery of antimicrobial agents, enhancing efficacy and reducing dosages.
- Various antibodies, antimicrobial payloads, and conjugation strategies have been developed for AACs.
- Recent applications demonstrate AACs' potential in treating diverse bacterial infections.
Conclusions:
- Antibody-antimicrobial conjugates (AACs) represent a significant advancement in the fight against antimicrobial resistance.
- Further research and development are needed to overcome challenges and fully realize the potential of AACs.
- AACs offer a promising therapeutic avenue for improved treatment of bacterial infections with reduced side effects.
More Related Videos
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Related Concept Videos
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antibiotic Selection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...